Saturday, July 11, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “therapy”

782 pharma patents match "therapy" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 782
Index total 30,257
Page 11 / 33

Quick answer

This filtered view shows 782 pharmaceutical patents matching "therapy" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

782 results for “therapy” · 30,257 patents in full index Clear search

  1. US 11234971

    Methods of treating cancer comprising administration of a glucocorticoid receptor modulator and a cancer chemotherapy agent

    Corcept Therapeutics Incorporated · Granted Feb 1, 2022 · Expires Jan 27, 2042

    granted

  2. US 11236139

    Combination immunotherapy

    The United States Government represented by the Department of Veterans Affairs · Granted Feb 1, 2022 · Expires Jan 27, 2042

    granted

  3. US 11219614

    Combination cancer therapy with pentaaza macrocyclic ring complex and ascorbate compound

    Galera Labs, LLC · Granted Jan 11, 2022 · Expires Jan 6, 2042

    granted

  4. US 11213514

    Alpha-1-adrenergic receptor agonist therapy

    The Regents of the University of California · Granted Jan 4, 2022 · Expires Dec 30, 2041

    granted

  5. US 11213592

    Antibody-sting agonist conjugates and their use in immunotherapy

    The Board of Regents of the University of Texas System · Granted Jan 4, 2022 · Expires Dec 30, 2041

    granted

  6. US 11207322

    Method and composition related to combination therapy for addiction

    The Board of Regents of the University of Texas System · Granted Dec 28, 2021 · Expires Dec 23, 2041

    granted

  7. US 11207339

    Targeted cancer therapy

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 28, 2021 · Expires Dec 23, 2041

    granted

  8. US 11202804

    Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy

    Iovance Biotherapeutics, Inc. · Granted Dec 21, 2021 · Expires Dec 16, 2041

    granted

  9. US 11202803

    Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy

    Iovance Biotherapeutics, Inc. · Granted Dec 21, 2021 · Expires Dec 16, 2041

    granted

  10. US 11197932

    Polymer-drug conjugates for combination anticancer therapy

    The Regents of the University of California · Granted Dec 14, 2021 · Expires Dec 9, 2041

    granted

  11. US 11192958

    Monoclonal antibodies for use in diagnosis and therapy of cancers and autoimmune disease

    The Board of Regents of the University of Texas System · Granted Dec 7, 2021 · Expires Dec 2, 2041

    granted

  12. US 11185585

    Methods and compositions for improving antiangiogenic therapy with anti-integrins

    The Regents of the University of California · Granted Nov 30, 2021 · Expires Nov 25, 2041

    granted

  13. US 11168303

    Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy

    Iovance Biotherapeutics, Inc. · Granted Nov 9, 2021 · Expires Nov 4, 2041

    granted

  14. US 11166936

    Pharmaceutical compositions and methods for countering chemotherapy induced cardiotoxicity

    Auransa Inc. · Granted Nov 9, 2021 · Expires Nov 4, 2041

    granted

  15. US 11168142

    Administration of kynurenine depleting enzymes for tumor therapy

    The Board of Regents of the University of Texas System · Granted Nov 9, 2021 · Expires Nov 4, 2041

    granted

  16. US 11168304

    Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy

    Iovance Biotherapeutics, Inc. · Granted Nov 9, 2021 · Expires Nov 4, 2041

    granted

  17. US 11160779

    Methods of providing solriamfetol therapy to subjects with impaired renal function

    Jazz Pharmaceuticals Ireland Limited · Granted Nov 2, 2021 · Expires Oct 28, 2041

    granted

  18. US 11154574

    Tumor infiltrating lymphocytes and methods of therapy

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 26, 2021 · Expires Oct 21, 2041

    granted

  19. US 11147837

    Modified cells and methods of therapy

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 19, 2021 · Expires Oct 14, 2041

    granted

  20. US 2021315993

    PHOTODYNAMIC THERAPY COMPRISING TWO LIGHT EXPOSURES AT DIFFERENT WAVELENGTHS

    BIOFRONTERA BIOSCIENCE GMBH [DE] · Granted Oct 14, 2021 · Expires Oct 9, 2041

    granted

  21. US 11129908

    Gene therapy vectors for treating heart disease

    Tenaya Therapeutics, Inc. · Granted Sep 28, 2021 · Expires Sep 23, 2041

    granted

  22. US 11116838

    Checkpoint inhibitor and vaccine combinations and use of same for immunotherapy

    Inovio Pharmaceuticals, Inc. · Granted Sep 14, 2021 · Expires Sep 9, 2041

    granted

  23. US 11118186

    Soluble interleukin-7 receptor (sIL7R) modulating therapy to treat autoimmune diseases and cancer

    The Board of Regents of the University of Texas System · Granted Sep 14, 2021 · Expires Sep 9, 2041

    granted

  24. US 11090290

    Clonidine and/or clonidine derivatives for use in the prevention of skin injury resulting from radiotherapy

    Monopar Therapeutics Inc. · Granted Aug 17, 2021 · Expires Aug 12, 2041

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.